FBT
First Trust NYSE Arca Biotechnology Index Fund
Price Chart
Latest Quote
$271.47
+2.22 (+0.82%)
Current Price
| Previous Close | $269.25 |
| Open | $270.44 |
| Day High | $272.69 |
| Day Low | $269.78 |
| Volume | 64,549 |
Fund Information
| Shares Outstanding | 20.85M |
| Net Assets | $2.97B |
| Expense Ratio | 0.55% |
| Category | Health |
| Fund Family | First Trust |
| Net Asset Value | $271.38 |
| Premium/Discount | 0.03% |
| P/E Ratio | 29.79 |
| Exchange | PCX |
đ ETF Analysis
Company Data
| Book/sh | $172.68 |
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 1.59 |
Analyst Data
Technical Indicators
| SMA20 | $267.24 |
| SMA50 | $268.32 |
| SMA200 | $231.99 |
| RSI | 61.43 |
| ATR | 4.9132 |
| Rel Volume | 0.72 |
Performance History
| Week | +0.72% |
| Month | +0.14% |
| Quarter | +9.29% |
| 6 Months | +34.66% |
| YTD | +31.77% |
| Year | +44.00% |
| 3 Years | +99.14% |
| 5 Years | +71.17% |
| 10 Years | +218.80% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $273.73 | 47,220 |
| 2026-10-26 | $271.47 | 64,500 |
| 2026-10-23 | $269.25 | 60,200 |
| 2026-10-22 | $272.68 | 55,300 |
| 2026-10-21 | $272.46 | 58,500 |
| 2026-10-20 | $271.77 | 82,600 |
| 2026-10-19 | $265.48 | 38,600 |
| 2026-10-16 | $263.60 | 49,300 |
| 2026-10-15 | $268.39 | 55,500 |
| 2026-10-14 | $262.95 | 39,800 |
| 2026-10-13 | $259.65 | 44,900 |
| 2026-10-12 | $263.90 | 26,300 |
| 2026-10-09 | $265.40 | 187,300 |
| 2026-10-08 | $260.19 | 72,500 |
| 2026-10-07 | $263.49 | 63,900 |
| 2026-10-06 | $264.97 | 71,500 |
| 2026-10-05 | $270.93 | 51,000 |
| 2026-10-02 | $266.44 | 51,100 |
| 2026-10-01 | $265.79 | 96,600 |
| 2026-09-30 | $272.26 | 101,400 |
| 2026-09-29 | $272.58 | 37,600 |
| 2026-09-28 | $273.36 | 99,800 |
About First Trust NYSE Arca Biotechnology Index Fund
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
đ° Latest News
No news articles available at the moment. Check back later for updates on FBT.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.